Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- WORLD NEW IN BRIEF
August 6, 2001
- Int'l Licensing Symposium to Be Held in Tokyo in September
August 6, 2001
- Gap between Boots and Mitsubishi Strategies Seen in Close of 4 Stores
August 6, 2001
- Only 5% of Migraine Sufferers Seek Professional Help: GSK Seminar
July 30, 2001
- Maker FTC Clarifies Rules Regarding Dispatch of Doctors Abroad
July 30, 2001
- Zyvox Effectiveness against VRE Reported: Pharmacia Forum
July 30, 2001
- Sanko Junyaku Patents Gene Amplification Method in the US
July 30, 2001
- Edible Plants Effective for Peripheral Neuropathy: Takara Shuzo
July 30, 2001
- REGULATORY NEWS IN BRIEF -2-
July 30, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -2-
July 30, 2001
- REGULATORY NEWS IN BRIEF -2-
July 30, 2001
- Most Top Management of Wholesalers Regard Current Sales Prices as Abnormal: Survey
July 30, 2001
- Ticlopidine Continues to Cause Serious ADRs: Korosho
July 30, 2001
- FALCO biosystems to Take Over Lab Test Business from Subsidiary
July 30, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -1-
July 30, 2001
- Checklist Issued for Clinical Trials of Medical Devices
July 30, 2001
- JMA, JDA, JPA Join Hands to Oppose Government's Reform Proposals
July 30, 2001
- Shimadzu: HPLC Autosampler SIL-HT
July 30, 2001
- Asahi Glass Ties Up with DMS Biologics to Contract to Manufacture Biotechnology Drugs
July 30, 2001
- Industry FTC to Prohibit Free Loan of Medical Devices
July 30, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…